Recurrent Pseudomonas aeruginosa Infection in Chronic Lung Diseases: Relapse or Reinfection?
- PMID: 25368663
- PMCID: PMC4217033
- DOI: 10.4046/trd.2014.77.4.172
Recurrent Pseudomonas aeruginosa Infection in Chronic Lung Diseases: Relapse or Reinfection?
Abstract
Background: Pseudomonas aeruginosa infection is particularly associated with progressive and ultimately chronic recurrent respiratory infections in chronic obstructive pulmonary disease, bronchiectasis, chronic destroyed lung disease, and cystic fibrosis. Its treatment is also very complex because of drug resistance and recurrence.
Methods: Forty eight cultures from 18 patients with recurrent P. aeruginosa pneumonia from 1998 to 2002 were included in this study. Two or more pairs of sputum cultures were performed during 2 or more different periods of recurrences. The comparison of strains was made according to the phenotypic patterns of antibiotic resistance and chromosomal fingerprinting by pulsed field gel electrophoresis (PFGE) using the genomic DNA of P. aeruginosa from the sputum culture.
Results: Phenotypic patterns of antibiotic resistance of P. aeruginosa were not correlated with their prior antibiotic exposition. Fifteen of 18 patients (83.3%) had recurrent P. aeruginosa pneumonia caused by the strains with same PFGE pattern.
Conclusion: These data suggest that the most of the recurrent P. aeruginosa infections in chronic lung disease occurred due to the relapse of prior infections. Further investigations should be performed for assessing the molecular mechanisms of the persistent colonization and for determining how to eradicate clonal persistence of P. aeruginosa.
Keywords: Electrophoresis, Gel, Pulsed-Field; Pneumonia; Pseudomonas aeruginosa.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Dowling RB, Wilson R. Pseudomonas aeruginosa respiratory infections. Clin Pulm Med. 1999;6:278–286.
-
- Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989;87:540–546. - PubMed
-
- Moss RB, Wunderink RG. Strategies for drug therapy in treating Pseudomonas infection. J Respir Dis. 1996;17:806–809.
-
- Fink MP, Snydman DR, Niederman MS, Leeper KV, Jr, Johnson RH, Heard SO, et al. The Severe Pneumonia Study Group. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother. 1994;38:547–557. - PMC - PubMed
-
- Rello J, Mariscal D, March F, Jubert P, Sanchez F, Valles J, et al. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med. 1998;157(3 Pt 1):912–916. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
